This trial is evaluating whether Blood Flow Restriction with Delfi Tourniquet System Cuff will improve 5 primary outcomes, 8 secondary outcomes, and 5 other outcomes in patients with Hip Fractures. Measurement will happen over the course of Post op 2 weeks.
This trial requires 20 total participants across 2 different treatment groups
This trial involves 2 different treatments. Blood Flow Restriction With Delfi Tourniquet System Cuff is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
One of the common side effects of blood flow restriction with delfi tourniquet system cuff was pain-associated with application of high level of pressure on the tourniquet cuff. We believe that further studies are needed before recommending its applications to a wide group of patients.
Patients sustaining a hip fracture are at high risk of dying, even after controlling for confounding factors. The risk of death at 1 year doubles the risk of death at 2 years. The risk of death after 2 years differs by age and by fracture location.
It was shown, that in Sweden as well as in other developed countries hip fractures are frequent. Hip fractures are classified as intrafemoral and extrafemoral. In Sweden, they occur in over 80% of male, and about 70% of female patients. Although they occur more often in elderly people, hip fractures also occur in middle-aged population. The occurrence of intrafemoral fractures increases with age, especially in geriatric females. In both sexes, type and place of occurrence and cause of the fractures vary greatly with age group and type of fracture.
These data suggest that hip fracture is prevalent in older Americans. Hip fracture accounts for 8 percent of all medical incidents and 16 percent of all hospital stays in the US.
Fracture line may be visible on x-rays of the pelvis. If a patient develops complications, such as persistent pain, it is important to suspect hip fracture.
In a recent study, findings proposes that occupational physical activity is a major causal factor for hip fracture among older adults in the community. Therefore, exercise should be strongly promoted among people aged 60 years and over.
Many patients are treated following a diagnosis of hip fracture through a wide variety of methods. Fracture fixation is commonly performed, and immobilization is common following fixation. However, most treatments are palliative treatments in that they are not aimed at minimizing the extent of a patient's disability, but rather are meant to manage complications related to fractures. These include pressure sores, and respiratory complications such as pneumonia and a decreased level of oxygen. In most cases, surgical intervention is not necessary.
A brief period of blood flow restriction with the DFB cuff system induces a redistribution of blood volume to muscle capillaries, and may reduce postoperative edema formation.
We have found only one clinical trial to investigate hip fractures in the past 10 years, and it has not been well equipped or funded to examine this important issue (NCT00547782, ClinicalTrials.gov). Patients are the best ambassadors for research topics, so we have initiated a short-term collaborative clinical trial to evaluate the effects of [combination medication management for hip fractures in older adults with diabetes mellitus, osteoporosis, dementia, frailty, and chronic kidney disease (COMPARATE), which is funded by the UK NHS Clinical Trials Register (UKCTR)-CTR25331638 (http://www.nhs.
There is adequate collateral blood flow to the ischemic limb, which is sufficient to keep the limb perfused, without causing ischemic complications. There are no signs of tissue damage and blood flow is improved from three to five minutes after application of the cuff.
About 45% of hip fracture patients suffer a hip fracture in their fifth decade of life. It is important to educate these patients about what to do after a hip fracture to prevent further complications.
Currently, no new treatments are approved for hip fractures for the treatment of post-fracture pain. However, we have been continually evaluating and improving our treatment algorithms based on advancements in fracture management. In order to provide more effective care to patients with hip fractures, we propose an improvement in fracture healing to prevent the development of post-fracture pain as well as prevention of complications.